{"id":"NCT02242643","sponsor":"GlaxoSmithKline","briefTitle":"Study to Evaluate the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine (GSK2282512A) Compared to Fluzone® Quadrivalent in Children 6 to 35 Months of Age","officialTitle":"Immunogenicity and Safety Study of GSK Biologicals' Quadrivalent Influenza Vaccine (GSK2282512A) Compared to Fluzone® Quadrivalent in Children 6 to 35 Months of Age","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-10-01","primaryCompletion":"2015-03-16","completion":"2015-06-23","firstPosted":"2014-09-17","resultsPosted":"2016-04-12","lastUpdate":"2018-09-07"},"enrollment":2432,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"PREVENTION"},"conditions":["Influenza"],"interventions":[{"type":"BIOLOGICAL","name":"FluLaval™ Quadrivalent","otherNames":["FLU Q-QIV (GSK2282512A)"]},{"type":"BIOLOGICAL","name":"Fluzone® Quadrivalent","otherNames":["F-QIV"]}],"arms":[{"label":"FluLaval™ Quadrivalent Group","type":"EXPERIMENTAL"},{"label":"Fluzone® Quadrivalent Group","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to assess the immunogenicity and safety of GSK Biologicals' quadrivalent influenza vaccine (GSK2282512A) compared to Sanofi Pasteur's Fluzone® Quadrivalent in children 6 to 35 months of age.","primaryOutcome":{"measure":"Haemagglutination Inhibition (HI) Antibody Titers Against Each of the 4 Vaccine Influenza Strains","timeFrame":"28 days after last vaccine dose (i.e. Day 28 for vaccine-primed subjects and Day 56 for vaccine-unprimed subjects)","effectByArm":[{"arm":"FluLaval™ Quadrivalent Group","deltaMin":716,"sd":null},{"arm":"Fluzone® Quadrivalent Group","deltaMin":660,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"6 Months","sex":"ALL","healthyVolunteers":true,"inclusionCount":5,"exclusionCount":11},"locations":{"siteCount":66,"countries":["United States","Mexico"]},"refs":{"pmids":[],"seeAlso":["https://www.clinicalstudydatarequest.com"]},"adverseEventsSummary":{"seriousAny":{"events":5,"n":1207},"commonTop":["Irritability/Fussiness","Pain","Drowsiness","Loss of Appetite","Fever"]}}